ABEO · Abeona Therapeutics Inc.
$6.18
+0.12 (+1.98%)
At close · Aug 25
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In accordance with Accounting Standards Codification ("ASC") 205-40, Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited interim condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$346.54M
Shares
57.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-13 | — | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-06-10 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | — | |
| 8-K | 2026-04-07 | 2026-04-01 | |
| 8-K | 2026-03-20 | 2026-03-16 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-18 | — | |
| 8-K | 2025-07-02 | 2025-06-27 | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-12 | 2025-05-09 | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-09 | 2024-12-31 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2024-12-20 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-08 | |
| DEF 14A | 2024-11-12 | — | |
| 8-K | 2024-10-29 | 2024-10-28 | |
| 8-K | 2024-08-14 | 2024-08-08 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-07-09 | 2024-07-05 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-03 | — | |
| 8-K | 2024-05-03 | 2024-05-02 | |
| 8-K | 2024-04-24 | — | |
| 8-K | 2024-04-22 | — | |
| DEF 14A | 2024-03-19 | — | |
| 10-K | 2024-03-18 | 2023-12-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 137 filings
Key facts
CIK
318306
CUSIP
00289Y206
13F (30d)
112 filings
111 filers
Visit website
Investor relations